Home
Search
Study Topics
Glossary
|
|
|
|
|
Tracking Information | |||||
---|---|---|---|---|---|
First Received Date † | August 20, 2008 | ||||
Last Updated Date | February 26, 2009 | ||||
Start Date † | April 2009 | ||||
Current Primary Outcome Measures † |
Admission time for elderly patients 65 years and older admitted to an Orthopedic Department [ Time Frame: October 2009 ] [ Designated as safety issue: No ] | ||||
Original Primary Outcome Measures † | Same as current | ||||
Change History | Complete list of historical versions of study NCT00738816 on ClinicalTrials.gov Archive Site | ||||
Current Secondary Outcome Measures † |
Time to first unscheduled physician contact(general practitioner,emergency department, ambulatory care or re-admission to hospital) after discharge from the Orthopaedic Department [ Time Frame: 3 and 12 month after admission date ] [ Designated as safety issue: No ] | ||||
Original Secondary Outcome Measures † | Same as current | ||||
Descriptive Information | |||||
Brief Title † | Effect of Systematic Medication Review in Elderly Patients Admitted to an Orthopedic Department | ||||
Official Title † | The Effect of Systematic Medication Review in Elderly Patients Admitted to an Orthopedic Department. | ||||
Brief Summary | Elderly patients have a higher risk of experiencing adverse drug events due to an age related increase in morbidity and medication use. Inappropriate or wrong medication use among elderly patients acutely admitted to hospitals is assumed to result in earlier contact to general practitioner, emergency departments and re-admissions if not corrected during hospital admission. It is therefore our hypothesis that a systematic medication review conducted by pharmacists and physicians specialized in pharmacology will increase time to first unscheduled physician contact (general practitioner, emergency departments, ambulatory care and re-admissions) after discharge from hospital from an average of 21days to 25 days. Further, the following secondary outcome parameters will be measured at 3 and 12 month follow-up:
|
||||
Detailed Description | |||||
Study Phase | |||||
Study Type † | Interventional | ||||
Study Design † | Prevention, Randomized, Open Label, Active Control, Parallel Assignment, Safety Study | ||||
Condition † | Elderly | ||||
Intervention † | Other: Systematic medication review and advisory notes | ||||
Study Arms / Comparison Groups | Other: Systematic medication review | ||||
Publications * |
|
||||
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline. |
|||||
Recruitment Information | |||||
Recruitment Status † | Not yet recruiting | ||||
Enrollment † | 100 | ||||
Estimated Completion Date | April 2010 | ||||
Estimated Primary Completion Date | October 2009 (final data collection date for primary outcome measure) | ||||
Eligibility Criteria † | Inclusion Criteria:
Exclusion Criteria:
|
||||
Gender | Both | ||||
Ages | 65 Years and older | ||||
Accepts Healthy Volunteers | No | ||||
Contacts †† |
|
||||
Location Countries † | Denmark | ||||
Expanded Access Status | |||||
Administrative Information | |||||
NCT ID † | NCT00738816 | ||||
Responsible Party | Marianne Lisby, Aarhus University Hospital | ||||
Secondary IDs †† | |||||
Study Sponsor † | Aarhus University Hospital | ||||
Collaborators †† | |||||
Investigators † |
|
||||
Information Provided By | University of Aarhus | ||||
Verification Date | February 2009 | ||||
† Required WHO trial registration data element. †† WHO trial registration data element that is required only if it exists. |